General Information of MIC (ID: MC0293)
  MIC Name
Clostridium asparagiforme DSM 15981
  Synonym
Clostridium asparagiforme DSM 15981, Clostridium sp. DSM 15981, Clostridium sp. N6
  Lineage Kingdom: Bacteria
Phylum: Firmicutes
Class: Clostridia
Order: Eubacteriales
Family: Lachnospiraceae
Genus: Enterocloster
  Oxygen Sensitivity
Obligate anaerobe
  Microbial Metabolism
Fermentative
  Gram
Positive
  Host Relationship
Commensal
  Genome Size (bp)
6224391
  No. of Coding Genes
6818
  No. of Non-Coding Genes
63
  No. of Small Non-Coding Genes
63
  No. of Gene Transcripts
6881
  Description
Clostridium asparagiforme DSM 15981 is a strain of obligate anaerobic, gram-positive, fermentative bacteria.
  External Links Taxonomy ID 518636
Genome Assembly ID ASM15807v1

Full List of Metabolite(s) Produced by This MIC
     Molecule Type: Amino acid (AAs)
           Metabolite Name: Tryptophan Click to Show/Hide
              Detailed Infomation Meta Info click to show the detail information of this Metabolite
              Metabolic Classification Microbial producted compound [precursors]
Modification Type Molecule EM Info Cell/Tissue Type Modified sites Condition REF
DNA Methylation ARL4C EM Info Hepatocellular CpG site: Cg15016771 non-alcoholic steatohepatitis [1], [2]
DNA Methylation CRTAC1 EM Info Hepatocellular CpG site: Cg03888360 non-alcoholic steatohepatitis [1], [2]
DNA Methylation COL4A1 EM Info Hepatocellular CpG site: Cg26090406 non-alcoholic steatohepatitis [1], [2]
DNA Methylation BMP2 EM Info Hepatocellular CpG site: Cg16831623 non-alcoholic steatohepatitis [1], [2]
DNA Methylation FAM100A EM Info Hepatocellular CpG site: Cg05009047 non-alcoholic steatohepatitis [1], [2]
DNA Methylation CLPTM1L EM Info Hepatocellular CpG site: Cg10641823 non-alcoholic steatohepatitis [1], [2]
DNA Methylation CLDN8 EM Info Hepatocellular CpG site: Cg06427867 non-alcoholic steatohepatitis [1], [2]
DNA Methylation C1QTNF1 EM Info Hepatocellular CpG site: Cg00193613 non-alcoholic steatohepatitis [1], [2]
DNA Methylation ZNF611 EM Info Hepatocellular CpG site: Cg27182293 non-alcoholic steatohepatitis [3], [2]
DNA Methylation FMNL2 EM Info Hepatocellular CpG site: Cg01467882 non-alcoholic steatohepatitis [4], [2]
DNA Methylation MCC EM Info Hepatocellular CpG site: Cg24094897 non-alcoholic steatohepatitis [4], [2]
DNA Methylation HDAC9 EM Info Hepatocellular CpG site: Cg16925459 non-alcoholic steatohepatitis [4], [2]
DNA Methylation FAM188B EM Info Hepatocellular CpG site: Cg02543636 non-alcoholic steatohepatitis [4], [2]
DNA Methylation SEMA3E EM Info Hepatocellular CpG site: Cg14519356 non-alcoholic steatohepatitis [4], [2]
DNA Methylation SLCO3A1 EM Info Hepatocellular CpG site: Cg03756778 non-alcoholic steatohepatitis [4], [2]
DNA Methylation FGD6 EM Info Hepatocellular CpG site: Cg21182715 non-alcoholic steatohepatitis [4], [2]
DNA Methylation TRPV6 EM Info Hepatocellular CpG site: Cg0642946 non-alcoholic steatohepatitis [4], [2]
DNA Methylation SLC22A20 EM Info Hepatocellular CpG site: Cg27428304 non-alcoholic steatohepatitis [4], [2]
DNA Methylation LGALS9 EM Info Hepatocellular CpG site: Cg27625456 non-alcoholic steatohepatitis [4], [2]
DNA Methylation ITGB4 EM Info Hepatocellular CpG site: Cg16916914 non-alcoholic steatohepatitis [4], [2]
DNA Methylation GRHL3 EM Info Hepatocellular CpG site: Cg02984188 non-alcoholic steatohepatitis [4], [2]
     Molecule Type: Fatty acids
           Metabolite Name: Acetate Click to Show/Hide
              Detailed Infomation Meta Info click to show the detail information of this Metabolite
              Metabolic Classification Microbial producted compound [end-products]
Modification Type Molecule EM Info Cell/Tissue Type Modified sites Condition REF
Histone Acetylation H3K27 EM Info HepG2 cells ACACA promoter Hypoxia [1], [2]
Histone Acetylation H3K27 EM Info HepG2 cells FASN promoter Hypoxia [1], [2]
Histone Acetylation H3K27 EM Info HepG2 cells LDHA promoter Hypoxia [1], [2]
Histone Acetylation H3K27 EM Info HepG2 cells VEGF promoter Hypoxia [1], [2]
Histone Acetylation H3K56 EM Info HepG2 cells ACACA promoter Hypoxia [1], [2]
Histone Acetylation H3K56 EM Info HepG2 cells FASN promoter Hypoxia [1], [2]
Histone Acetylation H3K56 EM Info HepG2 cells LDHA promoter Hypoxia [1], [2]
Histone Acetylation H3K56 EM Info HepG2 cells VEGF promoter Hypoxia [1], [2]
Histone Acetylation H3K9 EM Info HepG2 cells ACACA promoter Hypoxia [1], [2]
Histone Acetylation H3K9 EM Info HepG2 cells FASN promoter Hypoxia [1], [2]
Histone Acetylation H3K9 EM Info HepG2 cells LDHA promoter Hypoxia [1], [2]
Histone Acetylation H3K9 EM Info HepG2 cells VEGF promoter Hypoxia [1], [2]
Histone Deacetylation HDAC9 EM Info Eosinophil cell . Asthma [5], [2]
           Metabolite Name: Lactate Click to Show/Hide
              Detailed Infomation Meta Info click to show the detail information of this Metabolite
              Metabolic Classification Microbial producted compound [end-products]
Modification Type Molecule EM Info Cell/Tissue Type Modified sites Condition REF
miRNA miR-141-3P EM Info Oral epithelial cells . Autistic spectrum disorder [1], [2]


References
1 Serum aromatic and branched-chain amino acids associated with NASH demonstrate divergent associations with serum lipids. Liver Int. 2021 Apr;41(4):754-763. doi: 10.1111/liv.14743. Epub 2020 Dec 5.
2 The Virtual Metabolic Human database: integrating human and gut microbiome metabolism with nutrition and disease. Nucleic Acids Res. 2019 Jan 8;47(D1):D614-D624. doi: 10.1093/nar/gky992.
3 Potential Associations Among Alteration of Salivary miRNAs, Saliva Microbiome Structure, and Cognitive Impairments in Autistic Children. Int J Mol Sci. 2020 Aug 27;21(17):6203. doi: 10.3390/ijms21176203.
4 Acetate functions as an epigenetic metabolite to promote lipid synthesis under hypoxia. Nat Commun. 2016 Jun 30;7:11960. doi: 10.1038/ncomms11960.
5 Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites. Nat Commun. 2015 Jun 23;6:7320. doi: 10.1038/ncomms8320.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.